This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.
Conditions: Bladder Cancer
Eligibility Criteria
Inclusion Criteria
- Age between 18 and 75 years
- Body mass index \<35 kg/m2
- Bladder tumour located \<3 cm in size; clinically non-muscle invasive bladder tumour
- Clinically indicated for en-bloc resection.
- Willingness to participate as demonstrated by giving informed consent
Exclusion Criteria
- Presence of endoscopic or imaging signs of detrusor muscle invasion
- Contraindication to general anaesthesia / spinal anaesthesia
- ASA \> 2 patients
- Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
- Untreated active infection
- Un-corrected coagulopathy
- Presence of another malignancy or distant metastasis
- Emergency surgery
- Vulnerable population (e.g. mentally disabled, pregnant)
Eligibility criteria are kept as the original English records from ClinicalTrials.gov; actual eligibility is determined by the research team's formal assessment and the informed consent form. Source: ClinicalTrials.gov, updated automatically every two weeks. Last synced: 2026年10月8日.